AFG
IBRX icon

Atomi Financial Group’s ImmunityBio IBRX Stock Holding History

Atomi Financial Group’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$92.1K Hold
10,523
– – ﹤0.01% 1242
2026
Q1 		$80.7K Buy
10,523
+18
+0.2% +$123 ﹤0.01% 1194
2025
Q4 		$20.8K Buy
10,505
+500
+5% +$1.13K ﹤0.01% 1203
2025
Q3 		$24.6K Sell
10,005
-39
-0.4% -$100 ﹤0.01% 1165
2025
Q2 		$26.5K Buy
10,044
+20
+0.2% +$54 ﹤0.01% 1109
2025
Q1 		$30.2K Buy
+10,024
New +$30.4K ﹤0.01% 1033

Other funds holding IBRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Atomi Financial Group's IBRX Position: Q2 2026 in Review

Atomi Financial Group held its ImmunityBio (IBRX) position steady in Q2 2026 at 10,523 shares worth $92.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1242.

Atomi Financial Group first reported a position in IBRX in Q1 2025 and has held it in 6 quarters since. 405 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.

  • Atomi Financial Group held 10,523 shares of ImmunityBio worth $92.1K as of Q2 2026.
  • Atomi Financial Group left its ImmunityBio share count unchanged in Q2 2026.
  • ImmunityBio made up ﹤0.01% of Atomi Financial Group's portfolio in Q2 2026, its #1242 holding.
  • Atomi Financial Group first reported a position in ImmunityBio in Q1 2025 and has held it in 6 quarters since.
  • 405 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.

Based on Atomi Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.